Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-11

Clinical Trial Update: Medihoney® Derma Cream Treatment for Mild to Moderate Atopic Dermatitis in Children Study [Phase 2]

View source ↗

Summary

Phase 2 trial update for Medihoney Derma Cream in children with mild to moderate atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Medihoney Derma Cream

Snippet

Sponsor: Soroka University Medical Center | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED